Regulatory status is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2025-12-13. Where a claim depends on a specific study, the study is described rather than over-claimed.
Dihexa is a synthetic peptide studied in laboratory research. It is often described as an angiotensin IV analog or a hepatocyte growth factor mimetic. The compound emerged from investigations into angiotensin IV and its effects on neural pathways. It is not an approved medication, and controlled human trials are lacking. In literature and online forums, it is discussed mainly as a research chemical. Its chemical name appears as N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) in some sources.
Development of dihexa has been linked to academic research on synaptogenesis, the formation of new synapses. Preclinical studies in rodents have examined its effects on learning and memory tasks. These studies are often cited in discussions about cognitive enhancement, but they do not establish safety or efficacy in humans. The compound's patent and commercial history is limited, and it is not widely available through pharmaceutical channels. Most information comes from animal models and in vitro experiments. Researchers continue to explore its basic biology rather than clinical applications.
Dihexa is a synthetic compound studied in laboratory and animal models for effects on synaptic connectivity and cognitive performance. It is often described as a peptide analog because its structure incorporates amino acid residues linked to a hexanoic acid group. The molecule is not a naturally occurring human hormone or neurotransmitter. Its name appears in research literature and online discussions, but it has not been approved as a medicine by major regulatory agencies. Most information comes from preclinical experiments rather than controlled human trials.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 1401708-83-5 | Identifier used in chemical databases. |
| Common synonyms | P21; N-hexanoic-Tyr-Ile-(6-aminohexanoic amide) | Names vary by supplier and publication. |
| Physical form | White to off-white powder | Lyophilized solid typical of peptides. |
| Solubility | Soluble in DMSO; limited in water | Aqueous preparation may need a co-solvent. |
| Storage | -20 °C, desiccated, protected from light | Reduce freeze-thaw cycles to maintain stability. |
Regulatory status differs by country, but dihexa is generally not approved as a therapeutic product. It is often sold as a research chemical, which means purity, labeling, and handling fall outside pharmaceutical drug standards. Some jurisdictions restrict the sale of peptides intended for human consumption. Researchers and suppliers may therefore face different legal requirements depending on location. Import rules and customs enforcement can also affect how such compounds move across borders.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
The proposed mechanism of dihexa centers on activation of the hepatocyte growth factor receptor, also called c-Met. Some studies suggest it acts as a mimetic of hepatocyte growth factor, promoting signaling pathways involved in synapse formation. Other work has explored interactions with angiotensin IV pathways, but the exact binding targets remain uncertain. Laboratory findings come mainly from cell cultures and animal models. Whether these mechanisms operate similarly in humans is an open question. Researchers have not established a single, universally accepted mechanism of action.
Identity and purity of dihexa samples are typically assessed with high-performance liquid chromatography and mass spectrometry. These methods can confirm molecular mass and estimate the presence of impurities. However, a certificate of analysis from a supplier is not a guarantee of independent testing. Researchers often require in-house verification before using a peptide in experiments. For solid samples, appearance, solubility, and chromatographic profile provide additional checks. Nuclear magnetic resonance may be used for structural confirmation when available.
Dihexa is commonly handled as a lyophilized powder in laboratory settings. Storage at -20 °C in a desiccated, light-protected container is typical for peptides. Repeated freeze-thaw cycles can degrade the material, so aliquoting is often recommended. Aqueous solutions may be less stable than organic stocks and should be prepared fresh when possible. Personnel should follow institutional safety procedures and avoid uncontrolled exposure. Because human effects are not well characterized, handling precautions are prudent.
Colombia is ethnically diverse, its people descending from the original Native inhabitants, Spanish conquistadors, Africans originally brought to the country as slaves, and 20th-century immigrants from Europe and the Middle East, all contributing to a diverse cultural heritage. The demographic distribution reflects a pattern that is influenced by colonial history. Whites live all throughout the country, mainly in urban centers and the burgeoning highland and coastal cities. The populations of the major cities also include mestizos. Mestizo campesinos (people living in rural areas) also live in the Andean highlands where some Spanish conquerors mixed with the women of Amerindian chiefdoms. Mestizos include artisans and small tradesmen that have played a major part in the urban expansion of recent decades. In a study by the American Journal of Physical Anthropology, Colombians have an average ancestry of 47% Amerindian DNA, 42% European DNA, and 11% African DNA. The 2018 census reported that the "non-ethnic population", consisting of whites and mestizos (those of mixed European and Amerindian ancestry), constituted 87.6% of the national population. 6.7% is of African ancestry. Indigenous Amerindians constitute 4.3% of the population. Raizal people constitute 0.06% of the population. Palenquero people constitute 0.02% of the population. 0.01% of the population are Roma.
== See also == Ki Database Ion channel linked receptors Neuropsychopharmacology Schild regression for ligand receptor inhibition Signal transduction Stem cell marker List of MeSH codes (D12.776) Receptor theory
== Nuclear processes == A nuclide is considered to "exist" if it has a half-life greater than 2 ×10−14s. This is an arbitrary boundary; shorter half-lives are considered resonances, such as a system undergoing a nuclear reaction. This time scale is characteristic of the strong interaction which creates the nuclear force. Only nuclides are considered to decay and produce radioactivity. Nuclides can be stable or unstable. Unstable nuclides decay, possibly in several steps, until they become stable. There are 251 known stable nuclides. The number of unstable nuclides discovered has grown, with about 3000 known in 2006. The most common and consequently historically the most important forms of natural radioactive decay involve the emission of alpha-particles, beta-particles, and gamma rays. Each of these correspond to a fundamental interaction predominantly responsible for the radioactivity:
Sources: en.wikipedia.org
== Causes == The cause of JIA remains unknown. However, the disorder is autoimmune — meaning that the body's own immune system starts to attack and destroy cells and tissues (particularly in the joints) for no apparent reason. The immune system is thought to be provoked by changes in the environment, in combination with mutations in many associated genes and/or other causes of differential expression of genes. Experimental studies have shown that certain mutated viruses may be able to trigger JIA. The disease appears to be more common in girls, and is most common in Caucasians. The cause of JIA, as the word "idiopathic" suggests, is unknown and an area of active research. Current understanding of JIA suggests that it arises in a genetically susceptible individual due to environmental factors.
STE20/SPS1-related proline-alanine-rich protein kinase is an enzyme that in humans is encoded by the STK39 gene. This gene encodes a serine/threonine kinase that is thought to function in the cellular stress response pathway. The kinase is activated in response to hypotonic stress, leading to phosphorylation of several cation-chloride-coupled cotransporters. The catalytically active kinase specifically activates the p38 MAP kinase pathway, and its interaction with p38 decreases upon cellular stress, suggesting that this kinase may serve as an intermediate in the response to cellular stress. Some studies suggest that this gene might be linked to high blood pressure.
Betaine transporter (SLC6A12) InterPro: IPR002983 Creatine transporter (SLC6A8) InterPro: IPR002984 Dopamine neurotransmitter transporter (SLC6A3) InterPro: IPR002436 Inebriated neurotransmitter transporter InterPro: IPR002944 GABA neurotransmitter transporter GAT-1 (SLC6A1) InterPro: IPR002980 GABA neurotransmitter transporter GAT-2 (SLC6A13) InterPro: IPR002981 GABA neurotransmitter transporter GAT-3 (SLC6A11) InterPro: IPR002982 Glycine neurotransmitter transporter, type 1 (SLC6A9) InterPro: IPR003028 Noradrenaline neurotransmitter transporter (SLC6A2) InterPro: IPR002435 Orphan neurotransmitter transporter (SLC6A15) InterPro: IPR002438 Serotonin (5-HT) neurotransmitter transporter, N-terminal (SLC6A4) InterPro: IPR013086 Taurine transporter (SLC6A6) InterPro: IPR002434
However, the binary process happens merely because it is the most probable. In anywhere from two to four fissions per 1000 in a nuclear reactor, ternary fission can produce three positively charged fragments (plus neutrons) and the smallest of these may range from so small a charge and mass as a proton (Z = 1), to as large a fragment as argon (Z = 18). The most common small fragments, however, are composed of 90% helium-4 nuclei with more energy than alpha particles from alpha decay (so-called "long range alphas" at ~16 megaelectronvolts (MeV)), plus helium-6 nuclei, and tritons (the nuclei of tritium). Though less common than binary fission, it still produces significant helium-4 and tritium gas buildup in the fuel rods of modern nuclear reactors. Bohr and Wheeler used their liquid drop model, the packing fraction curve of Arthur Jeffrey Dempster, and Eugene Feenberg's estimates of nucleus radius and surface tension, to estimate the mass differences of parent and daughters in fission. They then equated this mass difference to energy using Einstein's mass-energy equivalence formula. The stimulation of the nucleus after neutron bombardment was analogous to the vibrations of a liquid drop, with surface tension and the Coulomb force in opposition. Plotting the sum of these two energies as a function of elongated shape, they determined the resultant energy surface had a saddle shape. The saddle provided an energy barrier called the critical energy barrier.
Sources: en.wikipedia.org
Both lepa1 and lepa2 have two characteristic cysteine residues which predict the formation of a disulfide bond in Lep, which is a pre-equisite for this 3D configuration and bioactivity of human LEP. The models suggest that the bonding of lepa2 might be different from lepa1. There are several differences between the 3D structures of lepa1 and lepa2; e.g. α-helix 5 is considerable shorter in lepa1 than lepa2. Furthermore, α-helix 1 for lepa2 appears to be split by a short-disordered region, and may therefore have a poorer affinity. However, considering that it is a predicted model based upon the structure mask of human LEP, the significance of these putative conformational adjustments remains to be tested. The importance of the conserved tertiary structure of Lep is most likely explained by requirements for specific LepR-binding affinity and is constrained by the structure of the receptor-binding pocket. This might also explain some of the results from studies on teleost using heterologous mammalian Lep. E.g. treatment with the mammalian hormone caused an anorexic effect in goldfish (Carassius auratus) and green sunfish (Lepomis cyanellus), but not in Coho salmon (Oncorhynchus kisutch), channel catfish (Ictalurus punctatus) and green sunfish. These contradicting results have been explained by the relatively large differences in amino acid sequences observed between mammals and fish. Rønnestad and colleagues recently detected five isoforms of the leptin receptor (lepr) that have differences in 3'-end of the mRNA sequence.
"Assassination on City Hall": dominated by Germans, the Execution Department of Worker's and Soldier's Council proceeded to Poznań's City Hall, an armed group of Poles forces it to change four of the German delegates with Polish ones: Bohdan Hulewicz, Mieczysław Paluch, Henryk Śniegocki and Zygmunt Wiza. Poles thus gain control over the headquarters of Poznań Garrison and 5th Corps. 17 November 1918: the Commission of the NRL calls for a one-time collection of money called a "national tax". 18 November 1918: elections to Poviat's People's Councils and members of the partition's Sejm (1399 MPs). 20 November 1918: the Polish government in Warsaw publishes przyłączenie Wielkopolski będzie jednym z pierwszych naszych zadań (the joining of Greater Poland will be one of our first tasks). 3 December 1918: The Partition Sejm of Poznań begins its official proceedings in the "Apollo" Cinema. MPs represent all lands of the Prussian Partition and Polish economic emigration, mainly from Westfalen. 5 December 1918: the end of the Partition Sejm, which declared its desire for unification with the other partitions in a renewed Poland, and the NRL officially elected its members. 6 December 1918: the first meeting of the NRL has Bolesław Krysiewicz become the speaker. Election of executive body, Commission of the NRL, formed by representatives of Greater Poland - Stanisław Adamski and Władysław Seyda; Upper Silesia: Wojciech Korfanty and Józef Rymer; Eastern Pomerania: Stefan Łaszewski; Kuyavia: Adam Poszwiński.
In classical homocystinuria (CBS, or cystathione beta synthase deficiency), the plasma methionine level usually increases above the normal range of 30 micromoles/L and the concentrations should be monitored as potentially toxic levels (more than 400 micromoles/L) may be reached.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide investigated in preclinical research. It is often classified as an angiotensin IV analog or an HGF mimetic. It is not an approved medicine.
No. Regulatory agencies have not approved dihexa for human use. It is sold as a research chemical in some markets, and human safety and efficacy data are lacking.
Laboratory studies have examined its effects on synapse formation and cognitive tasks in animals. These are early-stage findings. They do not prove benefits or safety in people.
Dihexa is a synthetic peptide-like compound studied primarily in preclinical models. It is often classified as an angiotensin IV analog and has been investigated for effects on neuronal connectivity. It is not an approved drug or dietary supplement.